Hasil Pencarian - Ali Ehsanpour

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Patient and Graft Survival of Kidney Allograft Recipients With Minimal Hepatitis C Virus Infection: A Case-Control Study

    Patient and Graft Survival of Kidney Allograft Recipients With Minimal Hepatitis C Virus Infection: A Case-Control Study oleh Ali Ehsanpour, Eskandar Hajiani, Heshmatollah Shahbazian

    Diterbitkan 2008-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Alterations in antibiotic susceptibility of urinary tract infection pathogens

    Alterations in antibiotic susceptibility of urinary tract infection pathogens oleh Ali Ghorbani, Ali Ehsanpour, Navid Roshanzamir, Bita Omidvar

    Diterbitkan 2012-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    The five-year survival of gastric cancer patients with a focus on its prognostic factors

    The five-year survival of gastric cancer patients with a focus on its prognostic factors oleh Abdolhassan Talaiezadeh, Mahsa Noroozi, Pedram Nazari, Ali Ehsanpour

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance

    Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance oleh Saeid Shahrabi, Ali Ehsanpour, Somayyeh Heidary, Mohammad Shahjahani, Masumeh Maleki Behzad

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The Expression Of Microvesicles In Leukemia: Prognostic Approaches

    The Expression Of Microvesicles In Leukemia: Prognostic Approaches oleh Ali Ehsanpour, Najmaldin Saki, Marziyeh Bagheri, Masumeh Maleki Behzad, Saeid Abroun

    Diterbitkan 2019-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Comparing the effect of self-care education and pain self-management on the nature of pain and quality of life in patients with sickle cell disease

    Comparing the effect of self-care education and pain self-management on the nature of pain and quality of life in patients with sickle cell disease oleh Seyyedeh Azadeh Moosapour, Nasrin Elahi, Noorollah Tahery, Mohammad Hosein Haghighizadeh, Ali Ehsanpour

    Diterbitkan 2021-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Lessons from monitoring, screening, evaluation and early detection of breast cancer in Iran

    Lessons from monitoring, screening, evaluation and early detection of breast cancer in Iran oleh Ali Ehsanpour, Amir Mohammad Papan, Shirin Kianpour, Pedram Nazari, Asieh Aref, Parastoo Ahangpour

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

    Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency cl... oleh Abolghasem Allahyari, Ali Ehsanpour, Nafiseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi, Mohsen Khani, Alireza Sadeghi, Sirus Gharib, Alireza Bary, Mehrzad Mirzania, Shirin Haghighat, Seyed Mohsen Razavi, Seyed Amir Hossein Emami, Mehran Hosseinzadeh, Mahdi Mirbolouk, Sanambar Sadighi, Abdolali Shahrasbi, Ali Esfahani, Masoumeh Gity, Nassim Anjidani, Hamidreza Kafi, Safa Najafi

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency clinical trial

    Correction: Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, eq... oleh Abolghasem Allahyari, Ali Ehsanpour, Behrouz Najafi, Nafseh Ansarinejad, Valiollah Mehrzad, Behjat Kalantari, Jahangir Raafat, Mojtaba Ghadiany, Farhad Shahi, Behrooz Gharib, Vahid Moazed, Adnan Khosravi, Mir Hossein Mirpour, Sina Salari, Seyedmohammadreza Mortazavizadeh, Amirabbas Nekoyi, Mohsen Khani, Alireza Sadeghi, Sirus Gharib, Alireza Bary, Mehrzad Mirzania, Shirin Haghighat, Seyed Mohsen Razavi, Seyed Amir Hossein Emami, Mehran Hosseinzadeh, Mahdi Mirbolouk, Sanambar Sadighi, Abdolali Shahrasbi, Ali Esfahani, Masoumeh Gity, Nassim Anjidani, Hamidreza Kaf, Safa Najaf

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: